Search Results

A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.

• Authors : Usdan L; Patel S ...

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1194-1203.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.

• Authors : Paternina-Caicedo A; ALZAK Foundation, Cartagena, Colombia; Universidad del Sinu, Cartagena, Colombia.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics SARS-CoV-2 variants

• Source: The Journal of infection [J Infect] 2024 Jun; Vol. 88 (6), pp. 106165. Date of Electronic Publication: 2024 Apr 24.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.

• Authors : Sieghart D; Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria.; Hana CA

Subjects: Immunization, Secondary* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

• Source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Aug; Vol. 173, pp. 105661. Date of Electronic Publication:Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9815671 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico.

• Authors : Ventura-Enríquez Y; Banco de Sangre, Centro Médico Naval (CEMENAV), Coyoacán, Ciudad de México 04470, Mexico.; Cortina-De la Rosa E

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Viruses [Viruses] 2024 Apr 01; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19).

• Authors : Canavati C; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (C.C., S.L., M.B., Y.T.), Jerusalem, Israel.; Hebrew University-Hadassah Faculty of Medicine (C.C., S.L., H.M.-S., Y.T., D.M.), Jerusalem, Israel.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced

• Source: Circulation [Circulation] 2024 Jan 16; Vol. 149 (3), pp. 270-273. Date of Electronic Publication: 2024 Jan 16.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Echocardiographic function evaluation in adolescents following BNT162b2 Pfizer-BioNTech mRNA vaccination: A preliminary prospective study.

• Authors : Hsu WF; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.; Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Myocarditis*/Myocarditis*/Myocarditis*/diagnostic imaging

• Source: Journal of the Chinese Medical Association : JCMA [J Chin Med Assoc] 2024 Jan 01; Vol. 87 (1), pp. 88-93. Date of Electronic Publication: 2023 Oct 26.Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients.

• Authors : Kawabe M; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Kuroda T

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Kidney Transplantation* COVID-19 vaccine booster shot

• Source: Scientific reports [Sci Rep] 2023 Jun 20; Vol. 13 (1), pp. 9976. Date of Electronic Publication: 2023 Jun 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

COVID-19 update: Pfizer bivalent vaccine booster dose for children 6 months to 4 years old.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; Immunization, Secondary*COVID-19 vaccine booster shot

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2023 Apr 17; Vol. 65 (1674), pp. 63-64.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis.

• Authors : Matson RP; nference, Cambridge, MA, USA.; Niesen MJM

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; Myocarditis* ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: The Lancet. Digital health [Lancet Digit Health] 2023 Apr; Vol. 5 (4), pp. e206-e216.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print Cited Medium: Internet ISSN: 2589-7500

Record details

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

• Authors : Canetti M; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.; Barda N

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use

• Source: The New England journal of medicine [N Engl J Med] 2022 Dec 01; Vol. 387 (22), pp. 2092-2094. Date of Electronic Publication: 2022 Nov 09.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details